D-0996-2019 Class III Terminated

Recalled by Lannett Company Inc. — Seymour, IN

FDA drug recall D-0996-2019 was initiated by Lannett Company Inc. on Feb 21, 2019 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 14,448 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 20, 2019
Initiation Date
Feb 21, 2019
Termination Date
Nov 6, 2020
Product Quantity
14,448 bottles

Product description

Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide, including Puerto Rico.

Code information

Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0996-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0996-2019. Report a data issue: hello@regdatalab.com.